NCT05836025View on ClinicalTrials.gov

Effect of Rapamycin in Ovarian Aging

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

September 30, 2026

Conditions
Perimenopausal
Interventions
DRUG

Rapamycin

5mg/week of rapamycin orally for 12 weeks

OTHER

Placebo

5mg/week of placebo orally for 12 weeks

Trial Locations (1)

10032

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER